Danhua Chemical TechnologyLtd Past Earnings Performance
Past criteria checks 0/6
Danhua Chemical TechnologyLtd's earnings have been declining at an average annual rate of -4%, while the Chemicals industry saw earnings growing at 6.2% annually. Revenues have been declining at an average rate of 8.7% per year.
Key information
-4.0%
Earnings growth rate
-4.1%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -8.7% |
| Return on equity | -84.1% |
| Net Margin | -54.8% |
| Next Earnings Update | 10 Oct 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Danhua Chemical TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 762 | -418 | 117 | 29 |
| 31 Mar 24 | 829 | -402 | 122 | 31 |
| 31 Dec 23 | 861 | -393 | 119 | 32 |
| 30 Sep 23 | 824 | -425 | 126 | 37 |
| 30 Jun 23 | 904 | -374 | 132 | 42 |
| 31 Mar 23 | 905 | -332 | 121 | 44 |
| 31 Dec 22 | 934 | -293 | 126 | 47 |
| 30 Sep 22 | 1,091 | -97 | 153 | 50 |
| 30 Jun 22 | 1,086 | -86 | 151 | 48 |
| 31 Mar 22 | 1,082 | -82 | 157 | 49 |
| 31 Dec 21 | 1,087 | -104 | 166 | 47 |
| 30 Sep 21 | 1,226 | -192 | 84 | 46 |
| 30 Jun 21 | 1,121 | -255 | 105 | 42 |
| 31 Mar 21 | 1,125 | -332 | 136 | 42 |
| 31 Dec 20 | 1,075 | -367 | 157 | 41 |
| 30 Sep 20 | 1,165 | -435 | 241 | 46 |
| 30 Jun 20 | 1,197 | -458 | 238 | 48 |
| 31 Mar 20 | 1,187 | -425 | 244 | 47 |
| 31 Dec 19 | 1,230 | -433 | 241 | 49 |
| 30 Sep 19 | 1,093 | -226 | 256 | 45 |
| 30 Jun 19 | 1,340 | -72 | 259 | 46 |
| 31 Mar 19 | 1,333 | -71 | 251 | 43 |
| 31 Dec 18 | 1,433 | 2 | 239 | 40 |
| 30 Sep 18 | 1,499 | 195 | 205 | 37 |
| 30 Jun 18 | 1,384 | 181 | 203 | 57 |
| 31 Mar 18 | 1,381 | 229 | 203 | 48 |
| 31 Dec 17 | 1,331 | 266 | 225 | 40 |
| 30 Sep 17 | 1,037 | 15 | 232 | 30 |
| 30 Jun 17 | 930 | -48 | 256 | 0 |
| 31 Mar 17 | 865 | -86 | 252 | 0 |
| 31 Dec 16 | 712 | -164 | 247 | 0 |
| 30 Sep 16 | 755 | -136 | 252 | 0 |
| 30 Jun 16 | 837 | -112 | 252 | 0 |
| 31 Mar 16 | 962 | -63 | 253 | 0 |
| 31 Dec 15 | 1,045 | -31 | 254 | 0 |
| 30 Sep 15 | 1,151 | 10 | 229 | 0 |
| 30 Jun 15 | 1,156 | 35 | 219 | 0 |
| 31 Mar 15 | 1,095 | 38 | 219 | 0 |
| 31 Dec 14 | 1,027 | 17 | 202 | 0 |
| 30 Sep 14 | 954 | -10 | 246 | 0 |
| 30 Jun 14 | 925 | -35 | 249 | 0 |
| 31 Mar 14 | 826 | -123 | 246 | 0 |
| 31 Dec 13 | 744 | -174 | 265 | 0 |
| 30 Sep 13 | 819 | -253 | 445 | 0 |
Quality Earnings: 900921 is currently unprofitable.
Growing Profit Margin: 900921 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 900921 is unprofitable, and losses have increased over the past 5 years at a rate of 4% per year.
Accelerating Growth: Unable to compare 900921's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 900921 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-4.8%).
Return on Equity
High ROE: 900921 has a negative Return on Equity (-84.1%), as it is currently unprofitable.